NCT01227356View on ClinicalTrials.gov

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

November 30, 2009

Conditions
Health Care QualityHealth Care Evaluation
Interventions
DRUG

imatinib and pegylated interferon

imatinib 400 mg p.o. daily pegylated interferon 50 ug s.c. weekly

Trial Locations (3)

S-75185

Bengt Simonsson, Uppsala

S-753 20

Uppsala University Hospital, Uppsala

S-75320

Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

lead

Uppsala University

OTHER

NCT01227356 - A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia | Biotech Hunter | Biotech Hunter